59–008 

114TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 2d Session 114–551 

PROVIDING FOR CONSIDERATION OF THE BILL (H.R. 4641) TO PROVIDE 

FOR THE ESTABLISHMENT OF AN INTER-AGENCY TASK FORCE TO REVIEW, MODIFY, AND UPDATE BEST PRACTICES FOR PAIN MANAGEMENT 

AND PRESCRIBING PAIN MEDICATION, AND FOR OTHER PURPOSES, AND 

PROVIDING FOR CONSIDERATION OF THE BILL (H.R. 5046) TO AMEND 

THE OMNIBUS CRIME CONTROL AND SAFE STREETS ACT OF 1968 TO AUTHORIZE THE ATTORNEY GENERAL TO MAKE GRANTS TO ASSIST STATE 

AND LOCAL GOVERNMENTS IN ADDRESSING THE NATIONAL EPIDEMIC 

OF OPIOID ABUSE, AND FOR OTHER PURPOSES 

MAY 10, 2016.—Referred to the House Calendar and ordered to be printed 

Mr. COLLINS of Georgia, from the Committee on Rules, 

submitted the following 

R E P O R T 

[To accompany H. Res. 720] 

The Committee on Rules, having had under consideration House 

Resolution 720, by a nonrecord vote, report the same to the House 

with the recommendation that the resolution be adopted. 

SUMMARY OF PROVISIONS OF THE RESOLUTION

The resolution provides for consideration of H.R. 4641, to provide 

for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing 

pain medication, and for other purposes, under a structured rule. 

The resolution provides one hour of general debate equally divided 

and controlled by the chair and ranking minority member of the 

Committee on Energy and Commerce. The resolution waives all 

points of order against consideration of the bill. The resolution 

makes in order as original text for the purpose of amendment the 

amendment in the nature of a substitute recommended by the 

Committee on Energy and Commerce now printed in the bill and 

provides that it shall be considered as read. The resolution waives 

all points of order against that amendment in the nature of a substitute. The resolution makes in order only those further amendments printed in part A of this report. Each such amendment may 

be offered only in the order printed in this report, may be offered 

only by a Member designated in this report, shall be considered as 

read, shall be debatable for the time specified in this report equally 

divided and controlled by the proponent and an opponent, shall not 

be subject to amendment, and shall not be subject to a demand for 


Lhorne on DSK30JT082PROD with HEARING
2 

division of the question in the House or in the Committee of the 

Whole. The resolution waives all points of order against the amendments printed in part A of this report. The resolution provides one 

motion to recommit with or without instructions. 

Section 2 of the resolution provides for consideration of H.R. 

5046, the Comprehensive Opioid Abuse Reduction Act of 2016, 

under a structured rule. The resolution provides one hour of general debate equally divided and controlled by the chair and ranking 

minority member of the Committee on the Judiciary. The resolution waives all points of order against consideration of the bill. The 

resolution makes in order as original text for the purpose of 

amendment an amendment in the nature of a substitute consisting 

of the text of Rules Committee Print 114–52 and provides that it 

shall be considered as read. The resolution waives all points of 

order against that amendment in the nature of a substitute. The 

resolution makes in order only those further amendments printed 

in part B of this report. Each such amendment may be offered only 

in the order printed in this report, may be offered only by a Member designated in this report, shall be considered as read, shall be 

debatable for the time specified in this report equally divided and 

controlled by the proponent and an opponent, shall not be subject 

to amendment, and shall not be subject to a demand for division 

of the question in the House or in the Committee of the Whole. The 

resolution waives all points of order against the amendments printed in part B of this report. The resolution provides one motion to 

recommit with or without instructions. 

EXPLANATION OF WAIVERS

Although the resolution waives all points of order against consideration of H.R. 4641, the Committee is not aware of any points of 

order. The waiver is prophylactic in nature. 

Although the resolution waives all points of order against the 

amendment in the nature of a substitute to H.R. 4641 made in 

order as original text, the Committee is not aware of any points of 

order. The waiver is prophylactic in nature. 

Although the resolution waives all points of order against the 

amendments to H.R. 4641 printed in part A of this report, the 

Committee is not aware of any points of order. The waiver is prophylactic in nature. 

The waiver of all points of order against consideration of H.R. 

5046 includes waiver of clause 3(e)(1) of rule XIII (‘‘Ramseyer’’), requiring a committee report accompanying a bill amending or repealing statutes to show, by typographical device, parts of statute 

affected. The waiver is provided because the submission provided 

by the Committee on the Judiciary was insufficient to meet the 

standards established by the rule in its current form. The Committee on Rules continues to work with the House Office of Legislative Counsel and committees to determine the steps necessary to 

comply with the updated rule. 

Although the resolution waives all points of order against the 

amendment in the nature of a substitute to H.R. 5046 made in 

order as original text, the Committee is not aware of any points of 

order. The waiver is prophylactic in nature. 

Although the resolution waives all points of order against the 

amendments to H.R. 5046 printed in part B of this report, the 


Lhorne on DSK30JT082PROD with HEARING
3 

Committee is not aware of any points of order. The waiver is prophylactic in nature. 

SUMMARY OF THE AMENDMENTS TO H.R. 4641 IN PART A MADE IN

ORDER

1. Brownley (CA): Adds the Office of Women’s Health. (10 minutes) 

2. Carter, Buddy (GA): Requires that any physician, dentists, 

non-physician prescriber or pharmacist who becomes a member of 

the Pain Management Best Practices Inter-Agency Task Force 

shall currently be licensed and practicing in their appropriate 

State. (10 minutes) 

3. Grayson (FL): Ensures that ‘‘first responders’’ are included for 

membership on the Pain Management Best Practices Inter-Agency 

Task Force. (10 minutes) 

4. Clark, Katherine (MA): Adds to the Task Force an expert in 

adolescent and young adult addiction, and a person in recovery 

from addiction to medication for chronic pain whose addiction 

began in adolescence or adulthood, and directs the Task Force to 

consider the distinct needs of adolescents and young adults in its 

development of best practices. (10 minutes) 

5. Moulton (MA), Zeldin (NY), Walz (MN): Adds representatives 

of Veteran Service Organizations to the Pain Management Best 

Practices Inter-Agency Task Force. (10 minutes) 

6. Nolan (MN): Inserts a representative on the task force for active duty military, armed forces personnel, and veteran health and 

prescription opioid addiction. (10 minutes) 

7. Watson Coleman (NJ): Inserts a minority health expert as a 

representative to the Pain Management Best Practices Inter-Agency Task Force established by this bill. (10 minutes) 

8. Kuster, Ann (NH), Guinta (NH): Requires that the task force 

research addiction trends in communities with high rates of prescription drug abuse. (10 minutes) 

9. Schiff (CA): Requires the Inter-Agency Task Force, as part of 

its duties to review and update best practices for pain management 

strategies, to also take into consideration the coordination of information collected from State prescription drug monitoring programs 

for the purpose of preventing the diversion of pain medication. (10 

minutes) 

10. Clark, Katherine (MA): Directs the Task Force to consider 

work done and any public comments submitted regarding electronic 

prescribing of opioids and its potential benefits, in the course of developing best practices. (10 minutes) 

11. Rothfus (PA), Keating (MA): Requires the inter-agency task 

force, as part of its review and update of best practices for pain 

management and prescribing pain medication, to also take into 

consideration the practice of co-prescribing the overdose reversal 

drug naloxone. (10 minutes) 

12. Clark, Katherine (MA): Directs the Task Force to consider, in 

the course of developing best practices, Federal agency programs 

and research relative to substance use and substance use disorders 

among adolescents and young adults, as well as any gaps identified 

by Federal government programs or researchers in the prevention 

of, treatment for, and recovery from substance use by and subVerDate Sep 11 2014 09:38 May 11, 2016 Jkt 059008 PO 00000 Frm 00003 Fmt 6659 Sfmt 6602 E:\HR\OC\HR551.XXX HR551

Lhorne on DSK30JT082PROD with HEARING
4 

stance use disorders among adolescents and young adults. (10 minutes) 

13. Esty (CT), Knight (CA): Requires the inter-agency task force 

to review, modify, and update best practices for pain management 

and prescribing pain medication, specifically as it pertains to physician education and consumer education. (10 minutes) 

14. Welch (VT), McKinley (WV): Expands the task force report to 

include information and recommendations on developing new nonopioid forms of pain relief. (10 minutes) 

15. Sessions (TX): Ensures the task force takes into consideration 

existing private sector, State, and local government efforts related 

to pain management and prescribing pain medication. (10 minutes) 

SUMMARY OF THE AMENDMENTS TO H.R. 5046 IN PART B MADE IN

ORDER

1. Donovan (NY), Turner (OH): Amends the Omnibus Crime Control and Safe Streets Act to include substance abuse treatment programs that provide alternatives to incarceration for pregnant 

women as eligible for family-based substance abuse treatment 

grants. (10 minutes) 

2. Davis, Danny K. (IL), Young (IN): Clarifies that grants addressing treatment alternatives to incarceration may include a 

focus on parents whose incarceration could result in their children 

entering foster care. (10 minutes) 

3. DelBene (WA): Clarifies that treatment alternative to incarceration programs may include community-based substance use diversion programs sponsored by a law enforcement agency. (10 minutes) 

4. DeSaulnier (CA), Carter, Buddy (GA): Clarifies that grants 

under this act can be used for multi-state interoperable prescription drug monitoring programs. (10 minutes) 

5. Bishop, Mike (MI): Adds an ‘‘allowable use’’ within the grant 

program established under the bill to develop, implement, or expand the use of programs that utilize secure containers for prescription drugs. (10 minutes) 

6. Guinta (NH), Kuster, Ann (NH): Adds treatment and recovery 

to the list of allowable uses in H.R. 5046. (10 minutes) 

7. Rothfus (PA): Expands the list of eligible grant uses for the 

Comprehensive Opioid Abuse Grant Program to include efforts to 

develop, implement, or expand a program to prevent and address 

opioid abuse by veterans. (10 minutes) 

8. Keating (MA), Rothfus (PA), Blumenauer (OR), Bera (CA), Roe 

(TN): Adds drug take-back programs to the list of authorized uses 

for amounts made available under Section 3021(a) of the Comprehensive Opioid Abuse Grant Program. (10 minutes) 

9. Lynch (MA): Provides that grant funding can be used develop, 

implement or expand a program to ensure the security of opioids 

in medical facilities. (10 minutes) 

10. Israel (NY), McKinley (WV), Mullin, Markwayne (OK): Directs the Attorney General, when awarding grants, to also consider 

community need based on prevalence of opioid abuse and related 

deaths. (10 minutes) 

11. Clark, Katherine (MA): Directs the GAO to study and report 

on Department of Justice programs and research relative to subVerDate Sep 11 2014 09:38 May 11, 2016 Jkt 059008 PO 00000 Frm 00004 Fmt 6659 Sfmt 6602 E:\HR\OC\HR551.XXX HR551

Lhorne on DSK30JT082PROD with HEARING
5 

stance use and substance use disorders among adolescents and 

young adults. (10 minutes) 

PART A—TEXT OF AMENDMENTS TO H.R. 4641 MADE IN ORDER

1. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE BROWNLEY

OF CALIFORNIA OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, line 11, strike ‘‘and’’. 

Page 4, line 13, insert ‘‘and’’ after the semicolon. 

Page 4, after line 13, insert the following: 

(M) the Office of Women’s Health; 

2. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CARTER OF

GEORGIA OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, line 15, strike ‘‘physicians’’ and insert ‘‘subject to subsection (d), physicians’’. 

Page 4, line 18, strike ‘‘pharmacists’’ and insert ‘‘subject to subsection (d), pharmacists’’. 

Page 5, after line 10, insert the following: 

(d) CONDITION ON PARTICIPATION ON TASK FORCE.—An individual 

representing a profession or entity described in paragraph (3) or (5) 

of subsection (c) may not serve as a member of the task force unless such individual— 

(1) is currently licensed in a State in which such individual 

is practicing (as defined by such State) such profession (or, in 

the case of an individual representing an entity, a State in 

which the entity is engaged in business); and 

(2) is currently practicing (as defined by such State) such 

profession (or, in the case of an individual representing an entity, the entity is in operation). 

Page 5, line 11, strike ‘‘(d)’’ and insert ‘‘(e)’’. 

Page 7, line 1, strike ‘‘(e)’’ and insert ‘‘(f)’’. 

Page 7, line 3, strike ‘‘(f)’’ and insert ‘‘(g)’’. 

3. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE GRAYSON

OF FLORIDA OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, after line 18, insert the following (and redesignate the 

subsequent paragraphs accordingly): 

(6) first responders; 

4. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CLARK OF

MASSACHUSETTS OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, after line 20, insert the following: 

(7) experts in the fields of adolescent and young adult addiction research; 

Page 4, line 21, strike ‘‘(7)’’ and insert ‘‘(8)’’. 

Page 5, line 6, strike ‘‘(8)’’ and insert ‘‘(9)’’. 

Page 5, after line 7, insert the following: 

(10) a person in recovery from addiction to medication for 

chronic pain, whose addiction began in adolescence or young 

adulthood; 


Lhorne on DSK30JT082PROD with HEARING
6 

Page 5, line 8, strike ‘‘(9)’’ and insert ‘‘(11)’’. 

Page 5, line 9, strike ‘‘(10)’’ and insert ‘‘(12)’’. 

Page 6, line 13, strike ‘‘and’’. 

Page 6, after line 13, insert the following: 

(E) the distinct needs of adolescents and young adults 

with respect to pain management, pain medication, substance use disorder, and medication-assisted treatment; 

and 

Page 6, line 14, strike ‘‘(E)’’ and insert ‘‘(F)’’. 

5. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE MOULTON

OF MASSACHUSETTS OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 5, line 3, strike ‘‘and’’. 

Page 5, after line 3, insert the following: 

(E) veteran service organizations; and 

Page 5, line 4, strike ‘‘(E)’’ and insert ‘‘(F)’’. 

6. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE NOLAN OF

MINNESOTA OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 5, line 8, strike ‘‘and’’. 

Page 5, after line 8, insert the following: 

(10) an expert on active duty military, armed forces personnel, and veteran health and prescription opioid addiction; 

Page 5, line 9, strike ‘‘(10)’’ and insert ‘‘(11)’’. 

7. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE WATSON

COLEMAN OF NEW JERSEY OR HER DESIGNEE, DEBATABLE FOR 10 

MINUTES

Page 5, line 8, strike ‘‘and’’. 

Page 5, after line 8, insert the following: 

(10) an expert in the field of minority health; and 

Page 5, line 9, strike ‘‘(10)’’ and insert ‘‘(11)’’. 

8. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE KUSTER OF

NEW HAMPSHIRE OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 5, after line 18, insert the following: 

(B) research on trends in areas and communities in 

which the prescription opioid abuse rate and fatality rate 

exceed the national average prescription opioid abuse rate 

and fatality rate; 

Page 5, line 19, strike ‘‘(B)’’ and insert ‘‘(C)’’. 

Page 5, line 22, strike ‘‘(C)’’ and insert ‘‘(D)’’. 

Page 6, line 6, strike ‘‘(D)’’ and insert ‘‘(E)’’. 

Page 6, line 14, strike ‘‘(E)’’ and insert ‘‘(F)’’. 

9. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE SCHIFF OF

CALIFORNIA OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, line 3, strike ‘‘and’’. 


Lhorne on DSK30JT082PROD with HEARING
7 

Page 6, line 5, before the semicolon insert ‘‘and the coordination 

of information collected from State prescription drug monitoring 

programs for the purpose of preventing the diversion of pain medication’’. 

10. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CLARK OF

MASSACHUSETTS OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, after line 5, insert the following: 

(D) ongoing efforts at the Federal, State, and local levels 

to examine the potential benefits of electronic prescribing 

of opioids, including any public comments collected in the 

course of those efforts; 

Page 6, line 6, strike ‘‘(D)’’ and insert ‘‘(E)’’. 

Page 6, line 14, strike ‘‘(E)’’ and insert ‘‘(F)’’. 

11. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE ROTHFUS

OF PENNSYLVANIA OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, line 13, strike ‘‘and’’. 

Page 6, after line 16, insert ‘‘and’’ after the semicolon. 

Page 6, after line 16, insert the following: 

(F) the practice of co-prescribing naloxone for both pain 

patients receiving chronic opioid therapy and patients 

being treated for opioid use disorders; 

12. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CLARK OF

MASSACHUSETTS OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, line 13, strike ‘‘and’’. 

Page 6, after line 16, insert the following: 

(F) research that has been, or is being, conducted or supported by the Federal Government on prevention of, treatment for, and recovery from substance use by and substance use disorders among adolescents and young adults 

relative to any unique circumstances (including social and 

biological circumstances) of adolescents and young adults 

that may make adolescent-specific and young adult-specific 

treatment protocols necessary, including any effects that 

substance use and substance use disorders may have on 

brain development and the implications for treatment and 

recovery; 

(G) Federal non-research programs and activities that 

address prevention of, treatment for, and recovery from 

substance use by and substance use disorders among adolescents and young adults, including an assessment of the 

effectiveness of such programs and activities in— 

(i) preventing substance use by and substance use 

disorders among adolescents and young adults; 

(ii) treating such adolescents and young adults in a 

way that accounts for any unique circumstances faced 

by adolescents and young adults; and 

(iii) supporting long-term recovery among adolescents and young adults; and 


Lhorne on DSK30JT082PROD with HEARING
8 

(H) gaps that have been identified by Federal officials 

and experts in Federal efforts relating to prevention of, 

treatment for, and recovery from substance use by and 

substance use disorders among adolescents and young 

adults, including gaps in research, data collection, and 

measures to evaluate the effectiveness of Federal efforts, 

and the reasons for such gaps; 

13. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE ESTY OF

CONNECTICUT OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, line 19, strike ‘‘and’’. 

Page 6, line 25, strike the period and insert ‘‘; and’’. 

Page 6, after line 25, insert the following: 

(4) review, modify, and update best practices for pain management and prescribing pain medication, specifically as it pertains to physician education and consumer education. 

Page 7, line 15, strike ‘‘and’’. 

Page 7, line 20, strike the period and insert ‘‘; and’’. 

Page 7, after line 20, insert the following: 

(4) the modified and updated best practices described in subsection (d)(4). 

14. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE WELCH

OF VERMONT OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, line 19, strike ‘‘and’’. 

Page 6, line 25, strike the period and insert ‘‘; and’’. 

Page 6, after line 25, insert the following: 

(4) examine and identify— 

(A) the extent of the need for the development of new 

pharmacological, nonpharmacological, and medical device 

alternatives to opioids; 

(B) the current status of research efforts to develop such 

alternatives; and 

(C) the pharmacological, nonpharmacological, and medical device alternatives to opioids that are currently available that could be better utilized. 

Page 7, line 15, strike ‘‘and’’. 

Page 7, line 20, strike the period and insert ‘‘; and’’. 

Page 7, after line 20, insert the following: 

(4) the results of the examination and identification conducted pursuant to subsection (d)(4), and recommendations regarding— 

(A) the development of new pharmacological, nonpharmacological, and medical device alternatives to 

opioids; and 

(B) the improved utilization of pharmacological, nonpharmacological, and medical device alternatives to opioids 

that are currently available. 


Lhorne on DSK30JT082PROD with HEARING
9 

15. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE SESSIONS

OF TEXAS OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 6, after line 25, insert the following (and redesignate the 

subsequent subsections accordingly): 

(e) CONSIDERATION OF STUDY RESULTS.—In reviewing, modifying, 

and updating, best practices for pain management and prescribing 

pain medication, the task force shall take into consideration existing private sector, State, and local government efforts related to 

pain management and prescribing pain medication. 

PART B—TEXT OF AMENDMENTS TO H.R. 5046 MADE IN ORDER

1. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE DONOVAN

OF NEW YORK OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 2, line 6, strike ‘‘part HH’’ and insert ‘‘part DD or HH’’. 

Add at the end of the bill the following: 

SEC. 6. INCLUSION OF SERVICES FOR PREGNANT WOMEN UNDER 

FAMILY-BASED SUBSTANCE ABUSE GRANTS. 

Part DD of title I of the Omnibus Crime Control and Safe Streets 

Act (42 U.S.C. 3797s et seq.) is amended— 

(1) in section 2921(2), by inserting before the period at the 

end ‘‘or pregnant women’’; and 

(2) in section 2927— 

(A) in paragraph (1)(A), by inserting ‘‘pregnant or’’ before 

‘‘a parent’’; and 

(B) in paragraph (3), by inserting ‘‘or pregnant women’’ 

after ‘‘incarcerated parents’’. 

2. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE DAVIS OF

ILLINOIS OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 2, line 14, strike ‘‘and’’. 

Page 2, line 17, strike the period at the end and insert ‘‘; and’’. 

Page 2, after line 17, insert the following: 

‘‘(F) a focus on parents whose incarceration could result 

in their children entering the child welfare system.’’. 

3. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE DELBENE

OF WASHINGTON OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 2, line 14, strike ‘‘and’’. 

Page 2, line 17, strike the period at the end and insert ‘‘; and’’. 

Page 2, after line 17, insert the following: 

‘‘(F) a community-based substance use diversion program sponsored by a law enforcement agency.’’. 

4. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE

DESAULNIER OF CALIFORNIA OR HIS DESIGNEE, DEBATABLE FOR

10 MINUTES

Page 3, line 21, insert after ‘‘providing for’’ the following: ‘‘interoperability and’’. 


Lhorne on DSK30JT082PROD with HEARING
10 

5. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE BISHOP OF

MICHIGAN OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, after line 3, insert the following: 

‘‘(9) Developing, implementing, or expanding a program 

(which may include demonstration projects) to utilize technology that provides a secure container for prescription drugs 

that would prevent individuals, particularly adolescents, from 

gaining access to opioid medications that are lawfully prescribed for other individuals.’’. 

6. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE GUINTA OF

NEW HAMPSHIRE OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, line 3, insert before the period at the end the following: 

‘‘, including prevention and recovery programs’’. 

7. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE ROTHFUS

OF PENNSYLVANIA OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, after line 3, insert the following: 

‘‘(9) Developing, implementing, or expanding a program to 

prevent and address opioid abuse by veterans.’’. 

8. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE KEATING

OF MASSACHUSETTS OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, after line 3, insert the following: 

‘‘(9) Developing, implementing, or expanding a prescription drug 

take-back program.’’. 

9. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE LYNCH OF

MASSACHUSETTS OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 4, after line 3, insert the following: 

‘‘(9) Developing, implementing, or expanding a program to 

ensure the security of opioids in medical facilities.’’. 

10. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE ISRAEL OF

NEW YORK OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 7, strike lines 3 through 7, and insert the following: 

‘‘SEC. 3024. EQUITABLE DISTRIBUTION OF FUNDS. 

‘‘In awarding grants under this part, the Attorney General shall 

ensure equitable distribution of funds based on the following: 

‘‘(1) The geographic distribution of grants under this part, 

taking into consideration the needs of underserved populations, 

including rural and tribal communities. 

‘‘(2) The needs of communities to address the problems related to opioid abuse, taking into consideration the prevalence 

of opioid abuse and overdose-related death in a community.’’. 


Lhorne on DSK30JT082PROD with HEARING
11 

11. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CLARK OF

MASSACHUSETTS OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Add at the end of the bill the following: 

SEC. 6. GAO STUDY AND REPORT ON DEPARTMENT OF JUSTICE PROGRAMS AND RESEARCH RELATIVE TO SUBSTANCE USE 

AND SUBSTANCE USE DISORDERS AMONG ADOLESCENTS 

AND YOUNG ADULTS. 

(a) STUDY.—The Comptroller General of the United States shall 

conduct a study on how the Department of Justice, through grant 

programs, is addressing prevention of, treatment for, and recovery 

from substance use by and substance use disorders among adolescents and young adults. Such study shall include an analysis of 

each of the following: 

(1) The research that has been, and is being, conducted or 

supported pursuant to grant programs operated by the Department of Justice on prevention of, treatment for, and recovery 

from substance use by and substance use disorders among adolescents and young adults, including an assessment of— 

(A) such research relative to any unique circumstances 

(including social and biological circumstances) of adolescents and young adults that may make adolescent-specific 

and young adult-specific treatment protocols necessary, including any effects that substance use and substance use 

disorders may have on brain development and the implications for treatment and recovery; and 

(B) areas of such research in which greater investment 

or focus is necessary relative to other areas of such research. 

(2) Department of Justice non-research programs and activities that address prevention of, treatment for, and recovery 

from substance use by and substance use disorders among adolescents and young adults, including an assessment of the effectiveness of such programs and activities in preventing substance use by and substance use disorders among adolescents 

and young adults, treating such adolescents and young adults 

in a way that accounts for any unique circumstances faced by 

adolescents and young adults, and supports long term recovery 

among adolescents and young adults. 

(3) Gaps that have been identified by officials of the Department of Justice or experts in the efforts supported by grant 

programs operated by the Department of Justice relating to 

prevention of, treatment for, and recovery from substance use 

by and substance use disorders among adolescents and young 

adults, including gaps in research, data collection, and measures to evaluate the effectiveness of such efforts, and the reasons for such gaps. 

(b) REPORT.—Not later than 2 years after the date of enactment 

of this Act, the Comptroller General shall submit to the appropriate committees of the Congress a report containing the results 

of the study conducted under subsection (a), including— 

(1) a summary of the findings of the study; and 

(2) recommendations based on the results of the study, including recommendations for such areas of research and legisVerDate Sep 11 2014 09:38 May 11, 2016 Jkt 059008 PO 00000 Frm 00011 Fmt 6659 Sfmt 6602 E:\HR\OC\HR551.XXX HR551

Lhorne on DSK30JT082PROD with HEARING
12 

lative and administrative action as the Comptroller General 

determines appropriate. 

Æ 


Lhorne on DSK30JT082PROD with HEARING